MET-2: Clinical Trials

3 trials of MET-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow MET-2: new trials by email Literature Review of MET-2 trials Research Report on MET-2

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder
MET-2 - Depression, Anxiety
Phase 1CompletedNuBiyota212019-05-162020-08-11
Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)
MET-2, Placebo oral capsule - Ulcerative Colitis
Phase 1CompletedNuBiyota112019-02-042021-05-03
MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)
MET-2, Vancomycin - Clostridium Difficile Infection
Phase 1CompletedNuBiyota192017-10-272020-08-11

Conditions studied

Anxiety Disorders (1)  ·  Clostridium Infections (1)  ·  Colitis, Ulcerative (1)  ·  Depression (1)  ·  Reinfection (1)

Sponsors

NuBiyota (3)

Countries

Canada (3)

Top investigators

Allan H Steinhart, MD (1)  ·  Dina Kao, MD (1)

Results publications

PMID 33631102, PMID 35060914